Is the National Institute for Health and Care Excellence (NICE) becoming more efficient in evaluatin...
Read moreThe purpose of this study is to compare the assessments of orphan and non-orphan drugs by NICE.
Read moreTo facilitate biosimilar uptake, several mechanisms aimed at reducing the acquisition cost of biosim...
Read moreHTA bodies and companies within the pharmaceutical industry have been forced to react to unprecedent...
Read moreThis study aimed to assess whether the new process has resulted in changes to outcomes of STAs.
Read moreThis study aimed to review timelines and use of financial agreements for products being appraised.
Read moreThis study investigates how gaps in the current evidence are linked to access restrictions and mitig...
Read moreIn this study, we compared the use of financial agreements for oncology and non-oncology drugs asses...
Read morePharmaceutical companies are incorporating payer / HTA needs into their clinical and commercial laun...
Read more